OORA Capital
OORA CAPITAL

Capital,
structured for
compounding.

A profit-linked capital architecture for OORA Skinlabs — the Korean-Protocol Beauty Clinic and medical aesthetic platform, building and operating dermatology clinics across Indonesia and APAC. Jakarta and Singapore-based, Korean-founded.

INVESTOR RELATIONS michael@oora.capital
MICHAEL (MINKYU) JEE
Founder  /  Managing Partner
BEAUTY RETURNS
“The most enduring structures are built where the water meets the rock.”
SEOUL SINGAPORE JAKARTA
INVESTMENT PHILOSOPHY

Expansion & balance,
compounded into upside.

We invest where the structural and the elemental meet — returns are sculpted at the boundary between efficiency and emotion. The growing beauty sector returns consistently high-margin earnings, like waves to shore.

Our edge is not financial engineering alone. We generate operational synergy, driving the underlying beauty business of OORA Skinlabs and translate those operating gains directly into investor yield through a PLAN (profit-linked asset note) architecture.

The result is additional venture upside generated by the business, not extracted from it.

OORA double-ring sigil
Michael (Minkyu) Jee
MICHAEL JEE  ㅣ  지민규

Founder, Capital

OORA Capital was the synthesis of trying to answer the question: “how do we expand clinics without crazy dilution or over-leveraging?” I found that answer in alignment — utilizing financial structures to alleviate cash burden for the clinic business while giving investors access to fast venture returns. The result is a natural harmony between OORA Skinlabs and OORA Capital.

My ten years in Web3 — as Korea Head of multiple top-10 global crypto exchanges, experience at startup, VC, and institutional finance — combine with my roots from Seoul & San Francisco to create a uniquely positioned opportunity if you are interested in K-/Beauty, Bio and Health Tech, and beauty venture returns.

If I'm not in Jakarta, I'm likely in Seoul or Singapore.

LINKEDIN
Tina (Yura) Hsu
TINA HSU  ㅣ  서유라

Founder, Skinlabs

I was fortunate to help IPO Day1Company — the Korean market leader for adult education — onto the KOSDAQ. As a startup executive who grew the team from 3 to 200 and drove $100M in revenue during my tenure as CIC (Lemonade) CEO of Day1 Company (373160.KQ), the mission is to improve the lives of women, starting with OORA Skinlabs.

I like to see business done the right way — ethically profitable, and serving a mission. And I love to see the glowing reactions from patients at our clinic after their treatments.

The large and fast-growing Jakarta beauty market is due for a market correction. OORA Skinlabs brings an authentically Korean accessible-premium brand — a disciplined-operator team with Korean-standard devices and quality — while offering 50% below our device-peers and 0–30% above price-peers. We are capturing the growth of the middle-upper market through best-in-class value, and invite you to find out more.

LINKEDIN
RESEARCH & CONCLUSIONS

Field notes.
COMING SOON

The Beauty Capital thesis.

How profit-linked instruments unlock dermatology infrastructure at scale — and why the next decade of beauty will be financed, not just funded.

COMING SOON

Spotlight, Dr. Minju Kang.

The clinical lead behind the OORA Skinlabs protocol — background, philosophy, and the practitioner's view on building a durable beauty platform.

COMING SOON

Spotlight, Pico Majesty.

A close look at the technology platform powering the next phase — what it does, why it matters, and how it integrates into the OORA clinical stack.